• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠心病患者血清抑瘤素M水平与冠状动脉狭窄程度的关系。

Relationship between serum oncostatin M levels and degree of coronary stenosis in patients with coronary artery disease.

作者信息

Li Xiaotao, Zhang Xiaoxia, Wei Liye, Xia Yue, Guo Xichao

机构信息

Department of Cardiology, Beijing Armed Police Corps Hospital, Beijing 100027, China.

Department of Cardiology, Beijing Anzhen Hospital, Capital University of Medical Science, Beijing 100029, China.

出版信息

Clin Lab. 2014;60(1):113-8. doi: 10.7754/clin.lab.2013.121245.

DOI:10.7754/clin.lab.2013.121245
PMID:24600984
Abstract

BACKGROUND

Oncostatin M (OSM) is an inflammatory cytokine which has been found to be expressed at sites of atherosclerotic lesions. We sought to investigate whether serum OSM levels are associated with coronary stenosis in patients with coronary artery disease (CAD).

METHODS

A total of 117 patients with CAD and 35 patients without CAD who underwent coronary angiography were enrolled in this study. Serum levels of OSM were measured by enzyme-linked immunosorbent assay. The severity of CAD was assessed by the number of diseased vessels and coronary stenosis score.

RESULTS

Serum OSM levels were significantly elevated in CAD patients compared with those without CAD. A stepwise increase in serum levels of OSM was also found depending on the number of > 50% coronary stenosis: median value 4.24 pg/mL (2.72 - 4.24) in 1-vessel disease, 6.44 pg/mL (4.87 - 10.09) in 2-vessel disease, and 7.83 pg/mL (5.41 - 10.37) in 3-vessel disease (p = 0.007 for trend). Correlation analysis showed coronary stenosis score positively correlated with age (r = 0.202, p = 0.029), current smoking (r = 0.210, p = 0.023), hypertension (r = 0.256, p = 0.005), TG (r = 0.408, p = 0.000), LDL-cholesterol (r = 0.325, p < 0.001), and hs-CRP (r = 0.307, p = 0.001), and correlated with OSM (r = 0.314, p < 0.001).

CONCLUSIONS

Our data suggest that increased serum OSM levels are associated with the coronary stenosis score and that circulating levels of this chemokine may reflect the extent of coronary atherosclerosis.

摘要

背景

抑瘤素M(OSM)是一种炎症细胞因子,已发现其在动脉粥样硬化病变部位表达。我们试图研究血清OSM水平是否与冠心病(CAD)患者的冠状动脉狭窄相关。

方法

本研究纳入了117例接受冠状动脉造影的CAD患者和35例无CAD患者。采用酶联免疫吸附测定法测量血清OSM水平。通过病变血管数量和冠状动脉狭窄评分评估CAD的严重程度。

结果

与无CAD患者相比,CAD患者血清OSM水平显著升高。根据冠状动脉狭窄>50%的数量,还发现血清OSM水平呈逐步升高:单支血管病变时中位数为4.24 pg/mL(2.72 - 4.24),双支血管病变时为6.44 pg/mL(4.87 - 10.09),三支血管病变时为7.83 pg/mL(5.41 - 10.37)(趋势p = 0.007)。相关性分析显示冠状动脉狭窄评分与年龄呈正相关(r = 0.202,p = 0.029)、与当前吸烟呈正相关(r = 0.210,p = 0.023)、与高血压呈正相关(r = 0.256,p = 0.005)、与甘油三酯呈正相关(r = 0.408,p = 0.000)、与低密度脂蛋白胆固醇呈正相关(r = 0.325,p < 0.001)以及与超敏C反应蛋白呈正相关(r = 0.307,p = 0.001),并且与OSM呈正相关(r = 0.314,p < 0.001)。

结论

我们的数据表明血清OSM水平升高与冠状动脉狭窄评分相关,并且这种趋化因子的循环水平可能反映冠状动脉粥样硬化的程度。

相似文献

1
Relationship between serum oncostatin M levels and degree of coronary stenosis in patients with coronary artery disease.冠心病患者血清抑瘤素M水平与冠状动脉狭窄程度的关系。
Clin Lab. 2014;60(1):113-8. doi: 10.7754/clin.lab.2013.121245.
2
Serum chemerin levels are associated with the presence and extent of coronary artery disease.血清chemerin水平与冠状动脉疾病的存在及严重程度相关。
Coron Artery Dis. 2012 Sep;23(6):412-6. doi: 10.1097/MCA.0b013e3283576a60.
3
Oncostatin M is a novel biomarker for coronary artery disease - A possibility as a screening tool of silent myocardial ischemia for diabetes mellitus.抑瘤素M是冠心病的一种新型生物标志物——作为糖尿病无症状心肌缺血筛查工具的可能性。
Int J Cardiol Heart Vasc. 2021 Jun 26;35:100829. doi: 10.1016/j.ijcha.2021.100829. eCollection 2021 Aug.
4
Fibroblast growth factor 23 is associated with the presence of coronary artery disease and the number of stenotic vessels.成纤维细胞生长因子23与冠状动脉疾病的存在及狭窄血管数量相关。
Clin Exp Pharmacol Physiol. 2015 Nov;42(11):1152-7. doi: 10.1111/1440-1681.12467.
5
Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.血清Lp-PLA2水平升高与冠状动脉疾病严重程度独立相关:一项中国人群的横断面研究
BMC Cardiovasc Disord. 2015 Feb 26;15:14. doi: 10.1186/s12872-015-0001-9.
6
Associations between plasma nesfatin-1 levels and the presence and severity of coronary artery disease.血浆核连蛋白-1水平与冠状动脉疾病的存在及严重程度之间的关联。
Heart Vessels. 2019 Jun;34(6):965-970. doi: 10.1007/s00380-018-01328-3. Epub 2019 Jan 1.
7
Relationship of serum Wnt1-inducible signaling pathway protein 1 levels with coronary artery disease and its severity.血清Wnt1诱导信号通路蛋白1水平与冠状动脉疾病及其严重程度的关系。
Coron Artery Dis. 2019 Nov;30(7):542-546. doi: 10.1097/MCA.0000000000000745.
8
Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease.稳定型缺血性心脏病患者的血浆 YKL-40 与冠状动脉疾病程度的关系。
Scand J Clin Lab Invest. 2011 Sep;71(5):439-47. doi: 10.3109/00365513.2011.586470.
9
Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness.血浆纤连蛋白水平及其与冠状动脉疾病和颈动脉内膜中层厚度的关联。
Coron Artery Dis. 2003 May;14(3):219-24. doi: 10.1097/01.mca.0000066454.28270.fb.
10
Plasma Soluble Endoglin Levels Are Inversely Associated With the Severity of Coronary Atherosclerosis-Brief Report.血浆可溶性内皮糖蛋白水平与冠状动脉粥样硬化严重程度呈负相关——简要报告
Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):49-52. doi: 10.1161/ATVBAHA.116.308494. Epub 2016 Oct 27.

引用本文的文献

1
Additional Benefits of Serum Oncostatin M Levels Compared to Cardiac Troponin in Non-ST Elevation Myocardial Infarction.与心肌肌钙蛋白相比,血清抑瘤素M水平在非ST段抬高型心肌梗死中的额外益处。
Acta Cardiol Sin. 2024 May;40(3):281-291. doi: 10.6515/ACS.202405_40(3).20240128A.
2
Decreased Serum Levels of Soluble Oncostatin M Receptor (sOSMR) and Glycoprotein 130 (sgp130) in Patients with Coronary Artery Disease.冠心病患者血清可溶性肿瘤坏死因子受体相关因子(sOSMR)和糖蛋白 130(sgp130)水平降低。
Arq Bras Cardiol. 2023 Mar;120(4):e20220326. doi: 10.36660/abc.20220326.
3
Association of increased oncostatin M with adverse left ventricular remodeling in patients with myocardial infarction.
心肌梗死患者中抑瘤素M升高与不良左心室重构的关联。
J Med Biochem. 2022 Oct 15;41(4):441-449. doi: 10.5937/jomb0-37150.
4
The Role of Interleukin-6 Family Members in Cardiovascular Diseases.白细胞介素-6家族成员在心血管疾病中的作用
Front Cardiovasc Med. 2022 Mar 23;9:818890. doi: 10.3389/fcvm.2022.818890. eCollection 2022.
5
Relationships among oncostatin M, insulin resistance, and chronic inflammation: a pilot study.抑瘤素M、胰岛素抵抗与慢性炎症之间的关系:一项初步研究。
Arch Endocrinol Metab. 2020 Feb;64(1):38-44. doi: 10.20945/2359-3997000000176. Epub 2019 Sep 30.
6
Oncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages.制瘤素M受体β缺陷通过抑制巨噬细胞中的JAK2/STAT3信号传导来减轻动脉粥样硬化的发生。
J Lipid Res. 2017 May;58(5):895-906. doi: 10.1194/jlr.M074112. Epub 2017 Mar 3.